218 related articles for article (PubMed ID: 12445295)
1. Effect of single and multiple doses of 0.2% brimonidine tartrate in the glaucomatous Beagle.
Gelatt KN; MacKay EO
Vet Ophthalmol; 2002 Dec; 5(4):253-62. PubMed ID: 12445295
[TBL] [Abstract][Full Text] [Related]
2. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
Gelatt KN; MacKay EO
Vet Ophthalmol; 2001 Dec; 4(4):283-8. PubMed ID: 11906665
[TBL] [Abstract][Full Text] [Related]
3. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
Gelatt KN; MacKay EO
Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
[TBL] [Abstract][Full Text] [Related]
4. Effect of different dose schedules of 0.15% unoprostone isopropyl on intraocular pressure and pupil size in the glaucomatous beagle.
Gelatt KN; Mackay EO; Dashiell T; Biken A
J Ocul Pharmacol Ther; 2004 Oct; 20(5):411-20. PubMed ID: 15650516
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
Plummer CE; MacKay EO; Gelatt KN
Vet Ophthalmol; 2006; 9(4):245-9. PubMed ID: 16771760
[TBL] [Abstract][Full Text] [Related]
6. Effect of different dose schedules of travoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
Gelatt KN; MacKay EO
Vet Ophthalmol; 2004; 7(1):53-7. PubMed ID: 14738508
[TBL] [Abstract][Full Text] [Related]
7. Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
Gelatt KN; Mackay EO
J Ocul Pharmacol Ther; 2002 Dec; 18(6):525-34. PubMed ID: 12537679
[TBL] [Abstract][Full Text] [Related]
8. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.
Liu CJ; Ko YC; Cheng CY; Chiu AW; Chou JC; Hsu WM; Liu JH
Ophthalmology; 2002 Dec; 109(12):2241-7. PubMed ID: 12466165
[TBL] [Abstract][Full Text] [Related]
9. Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States.
Camras CB; Sheu WP;
J Glaucoma; 2005 Apr; 14(2):161-7. PubMed ID: 15741820
[TBL] [Abstract][Full Text] [Related]
10. Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.
Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
Ophthalmology; 2014 Dec; 121(12):2348-55. PubMed ID: 25064721
[TBL] [Abstract][Full Text] [Related]
11. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.
Sherwood MB; Craven ER; Chou C; DuBiner HB; Batoosingh AL; Schiffman RM; Whitcup SM
Arch Ophthalmol; 2006 Sep; 124(9):1230-8. PubMed ID: 16966616
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma.
Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO
Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950
[TBL] [Abstract][Full Text] [Related]
13. Effect of Coherin™ on intraocular pressure, pupil size and heart rate in the glaucomatous Beagle: a pilot study.
MacKay EO; Gelatt KN
Vet Ophthalmol; 2013 May; 16(3):198-203. PubMed ID: 22853548
[TBL] [Abstract][Full Text] [Related]
14. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241
[TBL] [Abstract][Full Text] [Related]
15. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
[TBL] [Abstract][Full Text] [Related]
16. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
17. Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma.
Cho SW; Kim JM; Park KH; Choi CY
Jpn J Ophthalmol; 2010 Sep; 54(5):407-13. PubMed ID: 21052902
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes.
Wang RF; Serle JB; Gagliuso DJ; Podos SM
J Glaucoma; 2000 Dec; 9(6):458-62. PubMed ID: 11131752
[TBL] [Abstract][Full Text] [Related]
19. Brimonidine tartrate: a one-month dose response study.
Derick RJ; Robin AL; Walters TR; Barnebey HS; Choplin N; Schuman J; Kelley EP; Chen K; Stoecker JF
Ophthalmology; 1997 Jan; 104(1):131-6. PubMed ID: 9022117
[TBL] [Abstract][Full Text] [Related]
20. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
Simmons ST; Earl ML;
Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
